Tapewire

Nasdaq · USD

ISRG

INTUITIVE SURGICAL INC

Export transactions ↓
Tapewire entity
2878
SEC CIK
0001035267
Parsed reports
1,605

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202507
Jan 202606
Feb 202606
Mar 202609
Apr 202602
May 202606
Jun 202607
Jul 202605
Aug 202609
Sep 202606
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 10, 2024 Filed Dec 11, 2024 17:50 UTC
Samath JamieCFO and Head of Business Techn
SaleCommon Stock 135 $540.16 $72,920.93
Disclosure

SEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 4

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 17:50 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionCommon Stock 135 $229.39 $30,967.65
Disclosure

SEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 3

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 17:50 UTC
Samath JamieCFO and Head of Business Techn
SaleCommon Stock 135 $540.16 $72,920.93
Disclosure

SEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 2

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 17:50 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionCommon Stock 135 $304.67 $41,130.45
Disclosure

SEC source: 0001035267-24-000277 · edgardoc.xml · nonDerivative · entry 1

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:35 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 94 $0.00 Strike: $290.33 $0.00
Disclosure

SEC source: 0001035267-24-000273 · edgardoc.xml · derivative · entry 6

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,410

Underlying: Common Stock · 94 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:35 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 94 $0.00 Strike: $208.90 $0.00
Disclosure

SEC source: 0001035267-24-000273 · edgardoc.xml · derivative · entry 5

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,410

Underlying: Common Stock · 94 shares

Expires 2029-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:35 UTC
Samath JamieCFO and Head of Business Techn
SaleCommon Stock 94 $539.00 $50,666.00
Disclosure

SEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 4

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:35 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionCommon Stock 94 $208.90 $19,636.60
Disclosure

SEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 3

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:35 UTC
Samath JamieCFO and Head of Business Techn
SaleCommon Stock 94 $539.00 $50,666.00
Disclosure

SEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 2

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:35 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionCommon Stock 94 $290.33 $27,291.02
Disclosure

SEC source: 0001035267-24-000273 · edgardoc.xml · nonDerivative · entry 1

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:48 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 188 $0.00 Strike: $290.33 $0.00
Disclosure

SEC source: 0001035267-24-000275 · edgardoc.xml · derivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,820

Underlying: Common Stock · 188 shares

Expires 2029-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:48 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 188 $0.00 Strike: $208.90 $0.00
Disclosure

SEC source: 0001035267-24-000275 · edgardoc.xml · derivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,820

Underlying: Common Stock · 188 shares

Expires 2029-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:48 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 188 $539.00 $101,332.00
Disclosure

SEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,506

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:48 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 188 $208.90 $39,273.20
Disclosure

SEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:48 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 188 $539.00 $101,332.00
Disclosure

SEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,506

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 18:48 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 188 $290.33 $54,582.04
Disclosure

SEC source: 0001035267-24-000275 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:42 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 198 $0.00 Strike: $347.42 $0.00
Disclosure

SEC source: 0001035267-24-000269 · edgardoc.xml · derivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 597

Underlying: Common Stock · 198 shares

Expires 2031-08-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:42 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 198 $0.00 Strike: $245.60 $0.00
Disclosure

SEC source: 0001035267-24-000269 · edgardoc.xml · derivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 597

Underlying: Common Stock · 198 shares

Expires 2031-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:42 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 198 $542.06 $107,327.88
Disclosure

SEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,506

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:42 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 198 $245.60 $48,628.80
Disclosure

SEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,704

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:42 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 198 $542.06 $107,327.88
Disclosure

SEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,506

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 22:42 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 198 $347.42 $68,788.51
Disclosure

SEC source: 0001035267-24-000269 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,704

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 23:03 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 54 $0.00 Strike: $347.42 $0.00
Disclosure

SEC source: 0001035267-24-000271 · edgardoc.xml · derivative · entry 6

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159

Underlying: Common Stock · 54 shares

Expires 2031-08-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 23:03 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 54 $0.00 Strike: $245.60 $0.00
Disclosure

SEC source: 0001035267-24-000271 · edgardoc.xml · derivative · entry 5

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159

Underlying: Common Stock · 54 shares

Expires 2031-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 23:03 UTC
Samath JamieCFO and Head of Business Techn
SaleCommon Stock 54 $542.06 $29,271.24
Disclosure

SEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 4

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 23:03 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionCommon Stock 54 $245.60 $13,262.40
Disclosure

SEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 3

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 23:03 UTC
Samath JamieCFO and Head of Business Techn
SaleCommon Stock 54 $542.06 $29,271.24
Disclosure

SEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 2

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 26, 2024 Filed Nov 26, 2024 23:03 UTC
Samath JamieCFO and Head of Business Techn
Exercise / conversionCommon Stock 54 $347.42 $18,760.50
Disclosure

SEC source: 0001035267-24-000271 · edgardoc.xml · nonDerivative · entry 1

Samath Jamie · CIK 0001330269 · CFO and Head of Business Techn

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document
November 22, 2024 Filed Nov 22, 2024 20:56 UTC
Rosa David J.President
GiftCommon Stock 915 $0.00 $0.00
Disclosure

SEC source: 0001035267-24-000267 · edgardoc.xml · nonDerivative · entry 1

Rosa David J. · CIK 0001519593 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,080

F1 · kind: The filer gifted shares to The Rosa Donor Advised Fund.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,199 $0.00 Strike: $229.39 $0.00
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 12

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,829

Underlying: Common Stock · 2,199 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F5 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,010 $0.00 Strike: $208.90 $0.00
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 11

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,005

Underlying: Common Stock · 4,010 shares

Expires 2029-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F4 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $182.83 $0.00
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 10

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2029-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,257 $0.00 Strike: $177.99 $0.00
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · derivative · entry 9

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,257 shares

Expires 2030-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 4,010 $535.96 $2,149,187.17
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 8

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 298

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 4,010 $208.90 $837,689.00
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 7

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 2,199 $535.96 $1,178,569.22
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 6

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 298

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 2,199 $229.39 $504,428.61
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 5

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,497

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 5,000 $535.96 $2,679,784.50
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 4

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 298

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 5,000 $182.83 $914,166.50
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 3

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
SaleCommon Stock 2,257 $535.96 $1,209,654.72
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 2

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 298

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 21:21 UTC
Curet MyriamEVP & Chief Medical Officer
Exercise / conversionCommon Stock 2,257 $177.99 $401,715.98
Disclosure

SEC source: 0001035267-24-000265 · edgardoc.xml · nonDerivative · entry 1

Curet Myriam · CIK 0001632901 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 18:34 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 120 $0.00 Strike: $304.67 $0.00
Disclosure

SEC source: 0001035267-24-000261 · edgardoc.xml · derivative · entry 6

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,232

Underlying: Common Stock · 120 shares

Expires 2030-08-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

F3 · derivative.exercise_date: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 18:34 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 119 $0.00 Strike: $229.39 $0.00
Disclosure

SEC source: 0001035267-24-000261 · edgardoc.xml · derivative · entry 5

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,233

Underlying: Common Stock · 119 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

F2 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 18:34 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 119 $539.89 $64,246.91
Disclosure

SEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 4

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,506

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 18:34 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 119 $229.39 $27,297.41
Disclosure

SEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 3

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 18:34 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
SaleCommon Stock 120 $539.89 $64,786.80
Disclosure

SEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 2

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,506

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 18:34 UTC
DeSantis RobertEVP & Chief Strategy & Corp Op
Exercise / conversionCommon Stock 120 $304.67 $36,560.40
Disclosure

SEC source: 0001035267-24-000261 · edgardoc.xml · nonDerivative · entry 1

DeSantis Robert · CIK 0001808942 · EVP & Chief Strategy & Corp Op

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,626

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 00:16 UTC
Samath JamieSee Remarks
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 134 $0.00 Strike: $304.67 $0.00
Disclosure

SEC source: 0001610717-24-000519 · form4.xml · derivative · entry 30

Samath Jamie · CIK 0001330269 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,636

Underlying: Common Stock · 134 shares

Expires 2030-08-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

F6 · derivative.exercise_date: 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 00:16 UTC
Samath JamieSee Remarks
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 135 $0.00 Strike: $229.39 $0.00
Disclosure

SEC source: 0001610717-24-000519 · form4.xml · derivative · entry 29

Samath Jamie · CIK 0001330269 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,636

Underlying: Common Stock · 135 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

F5 · derivative.exercise_date: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 00:16 UTC
Samath JamieSee Remarks
SaleCommon Stock 269 $539.89 $145,230.41
Disclosure

SEC source: 0001610717-24-000519 · form4.xml · nonDerivative · entry 16

Samath Jamie · CIK 0001330269 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,757

F1 · kind: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.